TLR4 and neoplasm: Fusobacterium nucleatum exacerbates CRC progression by activating Toll-Like Receptor 4 (TLR4)/nuclear factor-κB (NF-κB) signaling and upregulating microRNA-21 expression, thereby increasing CRC cell proliferation and tumor burden in murine models [40].